| COVID-19 |
1 |
1 |
| Germany |
0 |
0.7 |
| Antigens |
0 |
0.56 |
| Health Insurance |
0 |
0.4 |
| Biologic Therapy |
0 |
0.35 |
| Insurance |
0 |
0.28 |
| Revenue and Practice Management |
0 |
0.27 |
| Renal Disease |
0 |
0.2 |
| Artificial Intelligence |
0 |
0.14 |
| Cardiovascular disease |
0 |
0.14 |
| Cough |
0 |
0.14 |
| Fever |
0 |
0.14 |
| Food and Drug Administration (FDA) |
0 |
0.14 |
| Kidney |
0 |
0.14 |
| Liver |
0 |
0.14 |
| Ohio |
0 |
0.14 |
| Polymerase Chain Reaction |
0 |
0.14 |
| Cardiovascular Risk Management |
0 |
0.09 |
| Healthcare and Medical Technology |
0 |
0.09 |
| Obesity |
0 |
0.09 |
| Otolaryngology |
0 |
0.09 |